Robeco Institutional Asset Management B.V. Biomarin Pharmaceutical Inc Transaction History

Robeco Institutional Asset Management B.V.

$60.3 Billion
Q2 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 641,718 shares of BMRN stock, worth $37.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

641,718

Previous 97,261 559.79%

Holding current value

$37.9 Million

Previous $6.88 Million 413.09%

% of portfolio

0.06%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$54.08 - $68.32 $29.4 Million - $37.2 Million	544,457 Added 559.79%	641,718 $35.3 Million
Q1 2025 Apr 23, 2025	BUY	$61.25 - $72.83 $654,578 - $778,334	10,687 Added 12.34%	97,261 $6.88 Million
Q4 2024 Jan 22, 2025	SELL	$61.93 - $70.49 $7.69 Million - $8.75 Million	-124,092 Reduced 58.9%	86,574 $5.69 Million
Q3 2024 Oct 29, 2024	BUY	$69.02 - $93.84 $8.89 Million - $12.1 Million	128,807 Added 157.35%	210,666 $14.8 Million
Q2 2024 Jul 22, 2024	BUY	$74.43 - $92.22 $1.97 Million - $2.44 Million	26,481 Added 47.82%	81,859 $6.74 Million
Q1 2024 Apr 24, 2024	BUY	$83.81 - $99.0 $3.47 Million - $4.1 Million	41,381 Added 295.64%	55,378 $4.84 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $9,298 - $12,018	122 Added 0.88%	13,997 $1.35 Million
Q4 2023 Feb 08, 2024	SELL	$76.22 - $98.51 $860,676 - $1.11 Million	-11,292 Reduced 44.87%	13,875 $14 Million
Q3 2023 Oct 23, 2023	SELL	$85.07 - $94.48 $258,868 - $287,502	-3,043 Reduced 10.79%	25,167 $2.23 Million
Q2 2023 Jul 24, 2023	SELL	$86.68 - $100.3 $580,322 - $671,508	-6,695 Reduced 19.18%	28,210 $2.45 Million
Q1 2023 May 03, 2023	BUY	$87.74 - $117.27 $407,113 - $544,132	4,640 Added 15.33%	34,905 $3.39 Million
Q4 2022 Feb 06, 2023	SELL	$80.93 - $108.63 $2.21 Million - $2.96 Million	-27,269 Reduced 47.4%	30,265 $3.13 Million
Q3 2022 Dec 01, 2022	BUY	$82.16 - $96.94 $315,658 - $372,443	3,842 Added 7.16%	57,534 $4.88 Million
Q3 2022 Oct 26, 2022	BUY	$82.16 - $96.94 $315,658 - $372,443	3,842 Added 7.16%	57,534 $4.88 Million
Q2 2022 Dec 01, 2022	BUY	$71.48 - $86.85 $283,060 - $343,926	3,960 Added 7.96%	53,692 $4.45 Million
Q2 2022 Jul 27, 2022	BUY	$71.48 - $86.85 $283,060 - $343,926	3,960 Added 7.96%	53,692 $4.45 Million
Q1 2022 Dec 01, 2022	BUY	$74.28 - $92.69 $3.47 Million - $4.33 Million	46,705 Added 1542.95%	49,732 $3.83 Million
Q1 2022 Apr 26, 2022	BUY	$74.28 - $92.69 $3.47 Million - $4.33 Million	46,705 Added 1542.95%	49,732 $3.83 Million
Q4 2021 Dec 01, 2022	BUY	$71.72 - $91.47 $2,366 - $3,018	33 Added 1.1%	3,027 $268,000
Q4 2021 Jan 31, 2022	BUY	$71.72 - $91.47 $2,366 - $3,018	33 Added 1.1%	3,027 $268,000
Q3 2021 Dec 01, 2022	SELL	$74.77 - $85.47 $385,663 - $440,854	-5,158 Reduced 63.27%	2,994 $231,000
Q3 2021 Oct 20, 2021	SELL	$74.77 - $85.47 $385,663 - $440,854	-5,158 Reduced 63.27%	2,994 $231,000
Q2 2021 Dec 01, 2022	SELL	$75.51 - $84.79 $390,613 - $438,618	-5,173 Reduced 38.82%	8,152 $680,000
Q2 2021 Jul 28, 2021	SELL	$75.51 - $84.79 $390,613 - $438,618	-5,173 Reduced 38.82%	8,152 $680,000
Q1 2021 Dec 01, 2022	SELL	$74.73 - $90.69 $3.3 Million - $4.01 Million	-44,209 Reduced 76.84%	13,325 $1.01 Million
Q1 2021 Apr 23, 2021	SELL	$74.73 - $90.69 $996,300 - $1.21 Million	-13,332 Reduced 50.01%	13,325 $1.01 Million
Q4 2020 Dec 01, 2022	SELL	$72.61 - $90.2 $2.24 Million - $2.79 Million	-30,877 Reduced 53.67%	26,657 $2.34 Million
Q4 2020 Jan 28, 2021	SELL	$72.61 - $90.2 $1.52 Million - $1.89 Million	-20,937 Reduced 43.99%	26,657 $2.34 Million
Q3 2020 Oct 29, 2020	SELL	$71.87 - $131.03 $787,407 - $1.44 Million	-10,956 Reduced 18.71%	47,594 $3.62 Million
Q2 2020 Jul 20, 2020	BUY	$79.55 - $124.22 $4.34 Million - $6.78 Million	54,605 Added 1384.16%	58,550 $7.22 Million
Q1 2020 Apr 30, 2020	BUY	$71.37 - $96.85 $9,991 - $13,559	140 Added 3.68%	3,945 $333,000
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $203,350 - $273,274	-3,164 Reduced 45.4%	3,805 $321,000
Q3 2019 Oct 17, 2019	BUY	$67.4 - $85.11 $151,178 - $190,901	2,243 Added 47.46%	6,969 $469,000
Q1 2019 May 02, 2019	BUY	$84.2 - $98.62 $131,520 - $154,044	1,562 Added 49.37%	4,726 $419,000
Q4 2017 Jan 25, 2018	BUY	$80.76 - $95.13 $255,524 - $300,991	3,164	3,164 $282,000

Others Institutions Holding BMRN

# of Institutions

666

Shares Held

185M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Biomarin Pharmaceutical Inc Transaction History